Request for Covid-19 Impact Assessment of this Report
The United States Dexlansoprazole market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Dexlansoprazole market, reaching US$ million by the year 2028. As for the Europe Dexlansoprazole landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Dexlansoprazole players cover Takeda, Cardinal Health, Suzhou Homesun Pharmaceutical, and Frontida, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Dexlansoprazole market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
30 mg
60 mg
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Gastroesophageal Reflux Disease
Heal Erosive Esophagitis
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Takeda
Cardinal Health
Suzhou Homesun Pharmaceutical
Frontida
Zhendong Group
Ouya Pharmaceutical
Heron Pharmaceutical
Sailong
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Dexlansoprazole Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Dexlansoprazole by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Dexlansoprazole by Country/Region, 2017, 2022 & 2028
2.2 Dexlansoprazole Segment by Type
2.2.1 30 mg
2.2.2 60 mg
2.3 Dexlansoprazole Sales by Type
2.3.1 Global Dexlansoprazole Sales Market Share by Type (2017-2022)
2.3.2 Global Dexlansoprazole Revenue and Market Share by Type (2017-2022)
2.3.3 Global Dexlansoprazole Sale Price by Type (2017-2022)
2.4 Dexlansoprazole Segment by Application
2.4.1 Gastroesophageal Reflux Disease
2.4.2 Heal Erosive Esophagitis
2.5 Dexlansoprazole Sales by Application
2.5.1 Global Dexlansoprazole Sale Market Share by Application (2017-2022)
2.5.2 Global Dexlansoprazole Revenue and Market Share by Application (2017-2022)
2.5.3 Global Dexlansoprazole Sale Price by Application (2017-2022)
3 Global Dexlansoprazole by Company
3.1 Global Dexlansoprazole Breakdown Data by Company
3.1.1 Global Dexlansoprazole Annual Sales by Company (2020-2022)
3.1.2 Global Dexlansoprazole Sales Market Share by Company (2020-2022)
3.2 Global Dexlansoprazole Annual Revenue by Company (2020-2022)
3.2.1 Global Dexlansoprazole Revenue by Company (2020-2022)
3.2.2 Global Dexlansoprazole Revenue Market Share by Company (2020-2022)
3.3 Global Dexlansoprazole Sale Price by Company
3.4 Key Manufacturers Dexlansoprazole Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Dexlansoprazole Product Location Distribution
3.4.2 Players Dexlansoprazole Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Dexlansoprazole by Geographic Region
4.1 World Historic Dexlansoprazole Market Size by Geographic Region (2017-2022)
4.1.1 Global Dexlansoprazole Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Dexlansoprazole Annual Revenue by Geographic Region
4.2 World Historic Dexlansoprazole Market Size by Country/Region (2017-2022)
4.2.1 Global Dexlansoprazole Annual Sales by Country/Region (2017-2022)
4.2.2 Global Dexlansoprazole Annual Revenue by Country/Region
4.3 Americas Dexlansoprazole Sales Growth
4.4 APAC Dexlansoprazole Sales Growth
4.5 Europe Dexlansoprazole Sales Growth
4.6 Middle East & Africa Dexlansoprazole Sales Growth
5 Americas
5.1 Americas Dexlansoprazole Sales by Country
5.1.1 Americas Dexlansoprazole Sales by Country (2017-2022)
5.1.2 Americas Dexlansoprazole Revenue by Country (2017-2022)
5.2 Americas Dexlansoprazole Sales by Type
5.3 Americas Dexlansoprazole Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Dexlansoprazole Sales by Region
6.1.1 APAC Dexlansoprazole Sales by Region (2017-2022)
6.1.2 APAC Dexlansoprazole Revenue by Region (2017-2022)
6.2 APAC Dexlansoprazole Sales by Type
6.3 APAC Dexlansoprazole Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Dexlansoprazole by Country
7.1.1 Europe Dexlansoprazole Sales by Country (2017-2022)
7.1.2 Europe Dexlansoprazole Revenue by Country (2017-2022)
7.2 Europe Dexlansoprazole Sales by Type
7.3 Europe Dexlansoprazole Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Dexlansoprazole by Country
8.1.1 Middle East & Africa Dexlansoprazole Sales by Country (2017-2022)
8.1.2 Middle East & Africa Dexlansoprazole Revenue by Country (2017-2022)
8.2 Middle East & Africa Dexlansoprazole Sales by Type
8.3 Middle East & Africa Dexlansoprazole Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Dexlansoprazole
10.3 Manufacturing Process Analysis of Dexlansoprazole
10.4 Industry Chain Structure of Dexlansoprazole
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Dexlansoprazole Distributors
11.3 Dexlansoprazole Customer
12 World Forecast Review for Dexlansoprazole by Geographic Region
12.1 Global Dexlansoprazole Market Size Forecast by Region
12.1.1 Global Dexlansoprazole Forecast by Region (2023-2028)
12.1.2 Global Dexlansoprazole Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Dexlansoprazole Forecast by Type
12.7 Global Dexlansoprazole Forecast by Application
13 Key Players Analysis
13.1 Takeda
13.1.1 Takeda Company Information
13.1.2 Takeda Dexlansoprazole Product Offered
13.1.3 Takeda Dexlansoprazole Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Takeda Main Business Overview
13.1.5 Takeda Latest Developments
13.2 Cardinal Health
13.2.1 Cardinal Health Company Information
13.2.2 Cardinal Health Dexlansoprazole Product Offered
13.2.3 Cardinal Health Dexlansoprazole Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Cardinal Health Main Business Overview
13.2.5 Cardinal Health Latest Developments
13.3 Suzhou Homesun Pharmaceutical
13.3.1 Suzhou Homesun Pharmaceutical Company Information
13.3.2 Suzhou Homesun Pharmaceutical Dexlansoprazole Product Offered
13.3.3 Suzhou Homesun Pharmaceutical Dexlansoprazole Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Suzhou Homesun Pharmaceutical Main Business Overview
13.3.5 Suzhou Homesun Pharmaceutical Latest Developments
13.4 Frontida
13.4.1 Frontida Company Information
13.4.2 Frontida Dexlansoprazole Product Offered
13.4.3 Frontida Dexlansoprazole Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Frontida Main Business Overview
13.4.5 Frontida Latest Developments
13.5 Zhendong Group
13.5.1 Zhendong Group Company Information
13.5.2 Zhendong Group Dexlansoprazole Product Offered
13.5.3 Zhendong Group Dexlansoprazole Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Zhendong Group Main Business Overview
13.5.5 Zhendong Group Latest Developments
13.6 Ouya Pharmaceutical
13.6.1 Ouya Pharmaceutical Company Information
13.6.2 Ouya Pharmaceutical Dexlansoprazole Product Offered
13.6.3 Ouya Pharmaceutical Dexlansoprazole Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Ouya Pharmaceutical Main Business Overview
13.6.5 Ouya Pharmaceutical Latest Developments
13.7 Heron Pharmaceutical
13.7.1 Heron Pharmaceutical Company Information
13.7.2 Heron Pharmaceutical Dexlansoprazole Product Offered
13.7.3 Heron Pharmaceutical Dexlansoprazole Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Heron Pharmaceutical Main Business Overview
13.7.5 Heron Pharmaceutical Latest Developments
13.8 Sailong
13.8.1 Sailong Company Information
13.8.2 Sailong Dexlansoprazole Product Offered
13.8.3 Sailong Dexlansoprazole Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Sailong Main Business Overview
13.8.5 Sailong Latest Developments
14 Research Findings and Conclusion
Table 1. Dexlansoprazole Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Dexlansoprazole Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 30 mg
Table 4. Major Players of 60 mg
Table 5. Global Dexlansoprazole Sales by Type (2017-2022) & (K Units)
Table 6. Global Dexlansoprazole Sales Market Share by Type (2017-2022)
Table 7. Global Dexlansoprazole Revenue by Type (2017-2022) & ($ million)
Table 8. Global Dexlansoprazole Revenue Market Share by Type (2017-2022)
Table 9. Global Dexlansoprazole Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Dexlansoprazole Sales by Application (2017-2022) & (K Units)
Table 11. Global Dexlansoprazole Sales Market Share by Application (2017-2022)
Table 12. Global Dexlansoprazole Revenue by Application (2017-2022)
Table 13. Global Dexlansoprazole Revenue Market Share by Application (2017-2022)
Table 14. Global Dexlansoprazole Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Dexlansoprazole Sales by Company (2020-2022) & (K Units)
Table 16. Global Dexlansoprazole Sales Market Share by Company (2020-2022)
Table 17. Global Dexlansoprazole Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Dexlansoprazole Revenue Market Share by Company (2020-2022)
Table 19. Global Dexlansoprazole Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Dexlansoprazole Producing Area Distribution and Sales Area
Table 21. Players Dexlansoprazole Products Offered
Table 22. Dexlansoprazole Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Dexlansoprazole Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Dexlansoprazole Sales Market Share Geographic Region (2017-2022)
Table 27. Global Dexlansoprazole Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Dexlansoprazole Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Dexlansoprazole Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Dexlansoprazole Sales Market Share by Country/Region (2017-2022)
Table 31. Global Dexlansoprazole Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Dexlansoprazole Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Dexlansoprazole Sales by Country (2017-2022) & (K Units)
Table 34. Americas Dexlansoprazole Sales Market Share by Country (2017-2022)
Table 35. Americas Dexlansoprazole Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Dexlansoprazole Revenue Market Share by Country (2017-2022)
Table 37. Americas Dexlansoprazole Sales by Type (2017-2022) & (K Units)
Table 38. Americas Dexlansoprazole Sales Market Share by Type (2017-2022)
Table 39. Americas Dexlansoprazole Sales by Application (2017-2022) & (K Units)
Table 40. Americas Dexlansoprazole Sales Market Share by Application (2017-2022)
Table 41. APAC Dexlansoprazole Sales by Region (2017-2022) & (K Units)
Table 42. APAC Dexlansoprazole Sales Market Share by Region (2017-2022)
Table 43. APAC Dexlansoprazole Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Dexlansoprazole Revenue Market Share by Region (2017-2022)
Table 45. APAC Dexlansoprazole Sales by Type (2017-2022) & (K Units)
Table 46. APAC Dexlansoprazole Sales Market Share by Type (2017-2022)
Table 47. APAC Dexlansoprazole Sales by Application (2017-2022) & (K Units)
Table 48. APAC Dexlansoprazole Sales Market Share by Application (2017-2022)
Table 49. Europe Dexlansoprazole Sales by Country (2017-2022) & (K Units)
Table 50. Europe Dexlansoprazole Sales Market Share by Country (2017-2022)
Table 51. Europe Dexlansoprazole Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Dexlansoprazole Revenue Market Share by Country (2017-2022)
Table 53. Europe Dexlansoprazole Sales by Type (2017-2022) & (K Units)
Table 54. Europe Dexlansoprazole Sales Market Share by Type (2017-2022)
Table 55. Europe Dexlansoprazole Sales by Application (2017-2022) & (K Units)
Table 56. Europe Dexlansoprazole Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Dexlansoprazole Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Dexlansoprazole Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Dexlansoprazole Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Dexlansoprazole Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Dexlansoprazole Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Dexlansoprazole Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Dexlansoprazole Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Dexlansoprazole Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Dexlansoprazole
Table 66. Key Market Challenges & Risks of Dexlansoprazole
Table 67. Key Industry Trends of Dexlansoprazole
Table 68. Dexlansoprazole Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Dexlansoprazole Distributors List
Table 71. Dexlansoprazole Customer List
Table 72. Global Dexlansoprazole Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Dexlansoprazole Sales Market Forecast by Region
Table 74. Global Dexlansoprazole Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Dexlansoprazole Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Dexlansoprazole Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Dexlansoprazole Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Dexlansoprazole Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Dexlansoprazole Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Dexlansoprazole Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Dexlansoprazole Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Dexlansoprazole Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Dexlansoprazole Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Dexlansoprazole Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Dexlansoprazole Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Dexlansoprazole Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Dexlansoprazole Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Dexlansoprazole Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Dexlansoprazole Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Dexlansoprazole Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Dexlansoprazole Revenue Market Share Forecast by Application (2023-2028)
Table 92. Takeda Basic Information, Dexlansoprazole Manufacturing Base, Sales Area and Its Competitors
Table 93. Takeda Dexlansoprazole Product Offered
Table 94. Takeda Dexlansoprazole Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. Takeda Main Business
Table 96. Takeda Latest Developments
Table 97. Cardinal Health Basic Information, Dexlansoprazole Manufacturing Base, Sales Area and Its Competitors
Table 98. Cardinal Health Dexlansoprazole Product Offered
Table 99. Cardinal Health Dexlansoprazole Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. Cardinal Health Main Business
Table 101. Cardinal Health Latest Developments
Table 102. Suzhou Homesun Pharmaceutical Basic Information, Dexlansoprazole Manufacturing Base, Sales Area and Its Competitors
Table 103. Suzhou Homesun Pharmaceutical Dexlansoprazole Product Offered
Table 104. Suzhou Homesun Pharmaceutical Dexlansoprazole Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. Suzhou Homesun Pharmaceutical Main Business
Table 106. Suzhou Homesun Pharmaceutical Latest Developments
Table 107. Frontida Basic Information, Dexlansoprazole Manufacturing Base, Sales Area and Its Competitors
Table 108. Frontida Dexlansoprazole Product Offered
Table 109. Frontida Dexlansoprazole Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Frontida Main Business
Table 111. Frontida Latest Developments
Table 112. Zhendong Group Basic Information, Dexlansoprazole Manufacturing Base, Sales Area and Its Competitors
Table 113. Zhendong Group Dexlansoprazole Product Offered
Table 114. Zhendong Group Dexlansoprazole Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. Zhendong Group Main Business
Table 116. Zhendong Group Latest Developments
Table 117. Ouya Pharmaceutical Basic Information, Dexlansoprazole Manufacturing Base, Sales Area and Its Competitors
Table 118. Ouya Pharmaceutical Dexlansoprazole Product Offered
Table 119. Ouya Pharmaceutical Dexlansoprazole Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. Ouya Pharmaceutical Main Business
Table 121. Ouya Pharmaceutical Latest Developments
Table 122. Heron Pharmaceutical Basic Information, Dexlansoprazole Manufacturing Base, Sales Area and Its Competitors
Table 123. Heron Pharmaceutical Dexlansoprazole Product Offered
Table 124. Heron Pharmaceutical Dexlansoprazole Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. Heron Pharmaceutical Main Business
Table 126. Heron Pharmaceutical Latest Developments
Table 127. Sailong Basic Information, Dexlansoprazole Manufacturing Base, Sales Area and Its Competitors
Table 128. Sailong Dexlansoprazole Product Offered
Table 129. Sailong Dexlansoprazole Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 130. Sailong Main Business
Table 131. Sailong Latest Developments
List of Figures
Figure 1. Picture of Dexlansoprazole
Figure 2. Dexlansoprazole Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Dexlansoprazole Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Dexlansoprazole Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Dexlansoprazole Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 30 mg
Figure 10. Product Picture of 60 mg
Figure 11. Global Dexlansoprazole Sales Market Share by Type in 2021
Figure 12. Global Dexlansoprazole Revenue Market Share by Type (2017-2022)
Figure 13. Dexlansoprazole Consumed in Gastroesophageal Reflux Disease
Figure 14. Global Dexlansoprazole Market: Gastroesophageal Reflux Disease (2017-2022) & (K Units)
Figure 15. Dexlansoprazole Consumed in Heal Erosive Esophagitis
Figure 16. Global Dexlansoprazole Market: Heal Erosive Esophagitis (2017-2022) & (K Units)
Figure 17. Global Dexlansoprazole Sales Market Share by Application (2017-2022)
Figure 18. Global Dexlansoprazole Revenue Market Share by Application in 2021
Figure 19. Dexlansoprazole Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Dexlansoprazole Revenue Market Share by Company in 2021
Figure 21. Global Dexlansoprazole Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Dexlansoprazole Revenue Market Share by Geographic Region in 2021
Figure 23. Global Dexlansoprazole Sales Market Share by Region (2017-2022)
Figure 24. Global Dexlansoprazole Revenue Market Share by Country/Region in 2021
Figure 25. Americas Dexlansoprazole Sales 2017-2022 (K Units)
Figure 26. Americas Dexlansoprazole Revenue 2017-2022 ($ Millions)
Figure 27. APAC Dexlansoprazole Sales 2017-2022 (K Units)
Figure 28. APAC Dexlansoprazole Revenue 2017-2022 ($ Millions)
Figure 29. Europe Dexlansoprazole Sales 2017-2022 (K Units)
Figure 30. Europe Dexlansoprazole Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Dexlansoprazole Sales 2017-2022 (K Units)
Figure 32. Middle East & Africa Dexlansoprazole Revenue 2017-2022 ($ Millions)
Figure 33. Americas Dexlansoprazole Sales Market Share by Country in 2021
Figure 34. Americas Dexlansoprazole Revenue Market Share by Country in 2021
Figure 35. United States Dexlansoprazole Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Dexlansoprazole Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Dexlansoprazole Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Dexlansoprazole Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Dexlansoprazole Sales Market Share by Region in 2021
Figure 40. APAC Dexlansoprazole Revenue Market Share by Regions in 2021
Figure 41. China Dexlansoprazole Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Dexlansoprazole Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Dexlansoprazole Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Dexlansoprazole Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Dexlansoprazole Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Dexlansoprazole Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Dexlansoprazole Sales Market Share by Country in 2021
Figure 48. Europe Dexlansoprazole Revenue Market Share by Country in 2021
Figure 49. Germany Dexlansoprazole Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Dexlansoprazole Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Dexlansoprazole Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Dexlansoprazole Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Dexlansoprazole Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Dexlansoprazole Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Dexlansoprazole Revenue Market Share by Country in 2021
Figure 56. Egypt Dexlansoprazole Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Dexlansoprazole Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Dexlansoprazole Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Dexlansoprazole Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Dexlansoprazole Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Dexlansoprazole in 2021
Figure 62. Manufacturing Process Analysis of Dexlansoprazole
Figure 63. Industry Chain Structure of Dexlansoprazole
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...